A 5-day course of cefdinir 300mg BID can treat both ear infections and Group A strep pharyngitis, but with important caveats
For acute otitis media (ear infections), cefdinir 300mg BID for 5 days is FDA-approved and effective, though it is not first-line therapy. For Group A streptococcal pharyngitis, while cefdinir is effective, the FDA-approved 5-day regimen cannot be endorsed due to insufficient evidence supporting shorter courses for strep throat.
Acute Otitis Media (Ear Infections)
FDA-Approved Indication
Cefdinir is FDA-approved for acute bacterial otitis media in pediatric patients at 7 mg/kg every 12 hours for 5-10 days or 14 mg/kg once daily for 10 days 1. For adults (300mg BID), this translates to an appropriate 5-day course for ear infections.
Clinical Efficacy Evidence
However, cefdinir is significantly less effective than first-line therapy. A high-quality 2012 RCT demonstrated that 10 days of high-dose amoxicillin/clavulanate achieved an 86.5% cure rate versus only 71.0% for 5 days of cefdinir (p=0.001) 2. Critically, cefdinir's efficacy decreased with increasing patient age/weight, suggesting the standard dosing may be inadequate 2.
When to Use Cefdinir for AOM
Cefdinir should be reserved for:
- Penicillin-allergic patients without anaphylactic-type reactions 3, 1
- Second-line therapy after amoxicillin failure 3
- Patients with documented beta-lactamase-producing organisms 4
First-line therapy remains high-dose amoxicillin (80-90 mg/kg/day) for 5-10 days depending on age and severity 3, 5.
Group A Streptococcal Pharyngitis
The 10-Day Standard
For strep throat, 10 days of antibiotic therapy is the established standard to achieve maximal pharyngeal eradication of Group A streptococci 6. This duration has been proven to prevent rheumatic fever and other suppurative complications.
Why 5 Days Cannot Be Endorsed for Strep
The IDSA 2012 guidelines explicitly state: "Currently, the US Food and Drug Administration has approved cefdinir for a 5-day course of therapy for GAS pharyngitis. However, many studies of short-course cephalosporin therapy lack strict entry criteria, include no assessment of compliance with therapy, and do not include serotypic or genotypic differentiation between infections for which treatment failed and newly acquired infections... Therefore, use of these shorter courses of oral cephalosporins cannot be endorsed at this time" 6.
Appropriate Cefdinir Use for Strep Throat
If cefdinir is chosen for strep pharyngitis (in penicillin-allergic patients without anaphylaxis):
- Use the 10-day regimen, not 5 days 6, 7
- Narrow-spectrum cephalosporins (cephalexin, cefadroxil) are preferred over broad-spectrum agents like cefdinir 6
- First-line remains penicillin or amoxicillin for 10 days (strong recommendation, high-quality evidence) 6
Critical Clinical Pitfalls
Common Prescribing Errors
A 2026 study found that 57% of pediatric cefdinir prescriptions were potentially inappropriate, with non-pediatric providers and emergency/urgent care settings showing higher rates of inappropriate use 8. The most common error is using cefdinir as first-line therapy when amoxicillin is indicated.
The Broader Spectrum Problem
Cefdinir has a much broader spectrum than penicillin, increasing the risk of selecting antibiotic-resistant flora and causing more adverse effects 6. It is also considerably more expensive than amoxicillin 6.
Dosing Considerations
The standard adult dose of cefdinir 300mg BID may be inadequate for larger patients, as efficacy correlates inversely with patient weight 2. This is particularly relevant for ear infections where treatment failures increase with age/weight.
Practical Algorithm
For Acute Otitis Media:
- First-line: High-dose amoxicillin 80-90 mg/kg/day for 5-10 days
- If penicillin allergy (non-anaphylactic): Cefdinir 300mg BID for 5-10 days is acceptable
- If treatment failure: Consider amoxicillin/clavulanate high-dose for 10 days
For Group A Strep Pharyngitis:
- First-line: Penicillin V or amoxicillin for 10 days
- If penicillin allergy (non-anaphylactic): First-generation cephalosporin (cephalexin preferred over cefdinir) for 10 days
- Do not use 5-day cefdinir regimen for strep throat—insufficient evidence for eradication and rheumatic fever prevention
Bottom line: While cefdinir 300mg BID for 5 days is FDA-approved and can treat ear infections (though less effectively than amoxicillin), it should not be used as a 5-day course for strep throat. For strep, use 10 days of therapy, and preferentially choose penicillin or amoxicillin as first-line agents.